Fredun Pharmaceuticals Ltd

NSE: FREDUN · BSE: 539730 · Pharmaceuticals & Biotechnology · 11 announcements

Share price: ₹1,360.90
Market cap: ₹1,944 Cr
Revenue (annual): ₹635.5 Cr
Net profit (annual): ₹32.62 Cr
P/E (TTM): 44.4×Sector 50.4×
Promoter holding: 44.57%+0.40% QoQ
FII holding: 1.06%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Earnings Call 3 Financial Results 2 Acquisition 2 Product Launch 1 Capital Structure Change 1 Business Update 1 Board Meeting Outcome 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

2 announcements with these filters

22 Sep 2026 09:20 IST BSE

Acquisition

Fredun Pharmaceuticals Acquisition Worth ₹300 Cr

Fredun Pharmaceuticals acquired a 26% stake in ₹300 Crore-valued Goodman Vetcare, a dedicated pet pharmacy chain. Plans target PAN-India expansion with ~₹100 Cr revenue by FY31.

Value: ₹300.0 Cr
new pet pharmacy stores planned: 8.0 stores

Read the filing ↗

8 Sep 2026 11:58 IST BSE

Acquisition

Fredun Pharmaceuticals Acquisition

Fredun Pharmaceuticals acquires pet-wellness brand Furlicks from USV and Wellbeing Nutrition. The deal marks strategic entry into India's pet-wellness market with plans to launch 44 new SKUs.

Read the filing ↗